Docetaxel in the management of ovarian cancer-Reference-Cited by-同舟云学术

Docetaxel in the management of ovarian cancer

Published:2005-04 Issue:2 Volume:5 Page:203-214
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Blagden Sarah P,Kaye Stan B

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.5.2.203

Reference97 articles.

1. The taxanes: toxicity and quality of life considerations in advanced ovarian cancer

2. Docetaxel and Cisplatin in Combination as First-Line Chemotherapy for Advanced Epithelial Ovarian Cancer

3. Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

4. Young RC, Perez CA, Hoskins WJ. Cancer of the ovary. In:Cancer: Principles and Practice of Oncology, 4th edition.deVita VT, Hellman S, Rosenberg SA (Eds), JB Lippincott Co., PA, USA, 1226–1263 (1993).

5. Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel methylcellulose based thermosenstive in situ nano liposomes of docetaxel for improved pharmacokinetics and pharmacodynamics with reduced toxicity;Materials Today Communications;2022-12

2. Formulation of Acid-Sensitive Micelles for Delivery of Cabazitaxel into Prostate Cancer Cells;Molecular Pharmaceutics;2016-03-24

3. A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy;Gynecologic Oncology;2013-07

4. Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations;Current Medicinal Chemistry;2010-06-01

5. Toxicology, Safety and Herb–drug Interactions in Cancer Therapy;Supportive Cancer Care with Chinese Medicine;2009-12-18